STAGE IV BREAST CANCER AJCC V6 AND V7
Clinical trials for STAGE IV BREAST CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BREAST CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV BREAST CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial aims to outperform standard hormone therapy for advanced breast cancer
Disease control OngoingThis study is comparing two hormone therapy drugs, tamoxifen and a newer drug called Z-Endoxifen, for postmenopausal women whose breast cancer has spread and is fueled by estrogen. The goal is to see if Z-Endoxifen can keep the cancer from growing for a longer period than the sta…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New hormone therapy tested for Tough-to-Treat breast cancer
Disease control OngoingThis early-stage trial is testing a new hormone therapy called Z-Endoxifen in women whose estrogen-positive breast cancer has returned or spread. The main goals are to find the safest dose and understand the drug's side effects. Participants take the drug daily in 28-day cycles w…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new drug duo in fight against spreading breast cancer
Disease control OngoingThis early-stage trial aims to find the safest and most effective dose of two drugs—cyclophosphamide and veliparib—when given together. It is for people with advanced breast cancer that has spread and is HER2-negative. The main goal is to understand the side effects and determine…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Scientists test drug duo to boost Cancer-Killing power
Disease control OngoingThis early-stage trial is testing a new combination of two drugs, veliparib and carboplatin, for people with advanced HER2-negative breast cancer that has spread. The main goals are to find the safest and most effective dose and to understand the side effects. Researchers hope th…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Triple-Threat attack on spreading breast cancer
Disease control OngoingThis study is testing whether adding an immunotherapy drug (pembrolizumab) to two standard breast cancer medications improves outcomes for postmenopausal women whose estrogen-driven breast cancer has spread. The goal is to see if this three-drug combination can shrink tumors and …
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New Heat-and-Zap combo fights spine tumors
Disease control OngoingThis study is testing whether using two treatments together works better than one to control cancer that has spread to the spine and is at risk of pressing on the spinal cord. Doctors combine a heat treatment (thermal ablation) that destroys tumor cells with a very precise, high-…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists test new drug duo to starve and stop advanced cancers
Disease control OngoingThis study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
Scientists test new pill cocktails in fight against tough cancers
Disease control OngoingThis early-stage trial is testing the safety and best doses of two different combinations of oral medications for people with recurrent endometrial, ovarian, or triple-negative breast cancer. The study combines an existing drug (olaparib) with one of two newer drugs (AZD2014 or A…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New scan could tell doctors which breast cancer treatment will work
Diagnosis OngoingThis study is testing a special imaging scan to see if it can predict whether hormone therapy will work for patients with advanced breast cancer that has spread. The scan uses a radioactive form of estrogen to 'light up' cancer spots in the body. If successful, this scan could he…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Mar 18, 2026 14:55 UTC
-
New scan tracks breast cancer treatment in real time
Knowledge-focused OngoingThis study is testing a special type of PET scan to see if it can measure how breast cancer tumors respond to hormone therapy. Researchers will scan patients before, during, and after treatment to see if changes in the scan images match how well the therapy is working. The goal i…
Matched conditions: STAGE IV BREAST CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC